Drug Research
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval. Rimegepant is commercialized as Nurtec® ODT in the U.S., and is indicated for the acute...
Drug Research
Phillips-Medisize and Exact Sciences Collaborate to Fight Colorectal Cancer
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection. Fueled by a relentless pursuit for smarter, earlier...
Drug Research
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery
Standigm Inc., the leading workflow artificial intelligence (AI) drug discovery company, announced that the company had established a Synthetic Research Center in the headquarters of SK Chemicals Co., Ltd, a life science and green chemicals company.
Standigm has dramatically improved...
Drug Research
IFF Displays Innovative Pharmaceutical Solutions, Tailored to Address Current, Future Industry Challenges
As the pharmaceutical industry continues to evolve – introducing increasingly complex drugs, unique applications and new dosage forms – the Pharma Solutions division of IFF is dedicated to helping formulators and manufacturers evolve alongside it. Armed with extensive expertise...
Drug Research
Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation gene editing tools, announced that the two companies have entered into a strategic research...
Drug Research
University of Kent research identifies novel Covid-19 therapy
Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19.
In order to multiply, all viruses, including coronaviruses, infect cells and reprogramme them to produce novel viruses. The research revealed that cells...
Drug Research
Pfizer and BioNTech Receive First U.S. FDA EUA of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Pfizer Inc. and BioNTech SE announced that the U.S. FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to <12 years). For this age group,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















